Innate Pharma
IPHA
#8351
Rank
S$0.22 B
Marketcap
$2.60
Share price
0.00%
Change (1 day)
-22.32%
Change (1 year)

Earnings for Innate Pharma (IPHA)

Earnings in 2023: -S$11.01 Million

According to Innate Pharma 's latest financial reports the company's current earnings are S$57.37 Million. In 2023 the company made an earning of -S$11.01 Million, an increase over its 2022 earnings that were of -S$81.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innate Pharma from 2005 to 2023

Annual earnings

Year Earnings Change
2023-S$11.01 Million-86.54%
2022-S$81.78 Million20.74%
2021-S$67.74 Million4951.09%
2020-S$1.35 Million-111.57%
2019S$11.59 M183.46%
2018S$4.08 M-105.4%
2017-S$75.77 Million-523.25%
2016S$17.9 M-285.64%
2015-S$9.65 Million-69.31%
2014-S$31.43 Million498.29%
2013-S$5.26 Million-5.62%
2012-S$5.57 Million-53.32%
2011-S$11.93 Million-50.1%
2010-S$23.9 Million-13.3%
2009-S$27.56 Million26.36%
2008-S$21.81 Million27.35%
2007-S$17.13 Million63.33%
2006-S$10.49 Million9.81%
2005-S$9.55 Million